grey glp 1 Effects of GLP-1 Medications on Skin + Skincare Don’t risk your health with

A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users

This difference was statistically significant ( p =0.037)

Accessed April 2026

161 However, these problems have not been shown to have a clear causal relationship with GLP-1RA in the general population, and there is a lack of data specific to the MASLD population, especially in individuals without co-existing T2DM

We aim to eliminate conflicting information and ensure every clinic is described in a trustworthy, transparent manner

Two independent 12 week studies reportedly showed reductions in cravings for sugar, fast food and salt while participants ate less and felt less hungry